-
Abstract Number: OC 56.3
Identification and Characterization of F9 Deep Intronic Variations in Haemophilia B Patients
-
Abstract Number: PB0813
Identification of a Common PROC Gene Mutation in Children with Moyamoya Disease Using Whole Exome Sequencing
-
Abstract Number: PB0112
Identification of a Novel PROC Mutation in a Newborn Causing Severe Protein C Deficiency Successfully Treated with Liver Transplantation
-
Abstract Number: PB0903
Identification of ADP P2y12 Receptor Defect by Functional Assays Using Algorithmic Approach – A Case Series
-
Abstract Number: OC 37.2
Identification of an Alternate Covalent Form of Platelet αIIbβ3 Integrin that Selectively Partitions into Focal Adhesions where it Has Extended Residency Time and Altered Function
-
Abstract Number: PB0960
Identification of Marginal Zone B Cells as Key Players in a Mouse Model of Platelet Alloimmunization
-
Abstract Number: OC 21.4
Identification of Novel Variants by Panel-based High-throughput Sequencing Associated with Platelet Function Disorders
-
Abstract Number: OC 23.4
Identification of Patients at High Thrombotic Risk in a Large Prospective Cancer Patient Cohort Undergoing Anticancer Treatment
-
Abstract Number: LPB0088
Identification of Small Interfering RNAs for Allele-selective Silencing of Murine von Willebrand Factor
-
Abstract Number: PB1103
Identification of Tumor-expressed MicroRNAs Associated with Venous Thrombosis in Colorectal Cancer
-
Abstract Number: PB0555
Identify Clinical and Laboratory Phenotypes of People with Hemophilia in Southwest Nigeria
-
Abstract Number: PB0152
Identifying Tools to Track Hypercoagulability in COVID-19 Patients. Exploring Global Haemostasis (ROTEM) and Neutrophil Extracellular Traps (NETs) Immunoassays
-
Abstract Number: PB0120
Identifying Vulnerable Patients with Direct Oral Anticoagulant (DOAC) Levels Outside the Expected Range
-
Abstract Number: PB0834
Idiopathic Thrombocytopenic Purpura: Conventional Prednisolone vs High-dose Dexamethasone
-
Abstract Number: OC 55.1
IgG2 as Hallmark of Inhibitor Persistence in a Longitudinal Analysis of PUPs in the First 50 Exposure Days to FVIII
-
Abstract Number: OC 36.3
Immature Platelet Count is Associated with Platelet Functional Responses in Patients Receiving Aspirin
-
Abstract Number: PB0825
Immature Platelet Fraction in Systemic Lupus Erythematosus-Related Thrombocytopenia: Potential Predictor of Platelet Response to Treatment?
-
Abstract Number: LPB0011
Immature Platelets as a Biomarker for Disease Severity and Mortality in COVID-19 Patients
-
Abstract Number: PB0455
Immune Complex Formation of Factor VIII (FVIII) with Inhibitors is Modulated by von Willebrand Factor (vWF)
-
Abstract Number: PB0377
Immune Mediators in Pediatric Patients with Chronic Kidney Disease
-
Abstract Number: PB0269
Immune Thrombocytopenia during Covid-19 Pandemic: An Italian Monocentric Experience
-
Abstract Number: PB0303
Immune Thrombocytopenia Purpura Associated with Novel Coronavirus Infection
-
Abstract Number: PO128
Immune Thrombocytopenia Refractory to Corticoid Therapy Secondary to Covid-19. A Single-centre Experience
-
Abstract Number: PB1011
Immune Thrombocytopenic Purpura: A Case Report
-
Abstract Number: PB0872
Immunofluorescence Staining of Blood Smears for the Diagnostics of Platelet Disorders: A Single-center Experience in a Pediatric Hospital
-
Abstract Number: PB0549
Immunogenicity and Safety of Simoctocog Alfa in Previously Treated Patients Switching to Simoctocog Alfa in the GENA Clinical Trial Programme
-
Abstract Number: OC 32.3
Immunogenicity in the Concizumab Phase 2 Clinical Trials: Clinical Impact of Anti-drug Antibodies
-
Abstract Number: PB0138
Immunothrombosis Biomarkers for Distinguishing COVID-19 Patients from Non-COVID Septic Pneumonia Patients and for Predicting ICU Mortality
-
Abstract Number: PB1108
Impact of a Smartphrase Venous Thromboembolism Risk Assessment Tool on Prophylaxis Prescribing Rates in a Gynecologic Oncology Clinic
-
Abstract Number: PB1049
Impact of ABO Incompatibility on the Outcome of Hematopoeitic Stem Cell Transplantation
-
Abstract Number: PB0454
Impact of Adherence to Prophylactic Treatment on Real-world Outcomes in Adults with Severe Haemophilia: A CHESS II Analysis in Europe
-
Abstract Number: LPB0061
Impact of Characteristic Inhibition Kinetics of Different FVIII Inhibitors on the Inhibitor Titer Quantification in the Modified Nijmegen-Bethesda Assay
-
Abstract Number: PB0252
IMPACT of COVID-19 Associated Coagulopathy in Disease Severity
-
Abstract Number: PB0137
Impact of COVID-19 on Platelet Activity and the Platelet Releasate
-
Abstract Number: PB0576
Impact of COVID-19 Pandemic on the Joint Bleeding Pattern and Prophylactic Management of Hemophilia Patients: A Single Centre Study in a Tertiary Care Centre of Eastern India
-
Abstract Number: PB0205
Impact of COVID-19 Pandemic on the Quality and Performance of Haemostasis Laboratories
-
Abstract Number: PB0130
Impact of DNA on the Fibrin Clot Structure in Peritoneal Carcinomatosis Patients
-
Abstract Number: LPB0001
Impact of Heparin Induced Thrombocytopenia on the Outcomes of Hospitalizations for Acute Myocardial Infarction: Analysis of National Inpatient Sample
-
Abstract Number: PB0713
Impact of Inherited Bleeding Disorders on Pregnancy and Postpartum Hemorrhage
-
Abstract Number: PB0901
Impact of Iron Deficiency Anemia on Bleeding Management in Pediatric Patients with Bernard-Soulier Syndrome and Glanzmann Thrombasthenia: A Single-institution Analysis
-
Abstract Number: PB0561
Impact of Prophylactic Treatment on Employment and Disability in Persons with Hemophilia
-
Abstract Number: PB0589
Impact of Switching to Recombinant Factor IX Fc Fusion Protein Prophylaxis: A Qualitative Study
-
Abstract Number: PB1021
Impact of the Common GPVI Polymorphism Is Limited to Intracellular Calcium Response upon Activation
-
Abstract Number: PB0217
Impact of the COVID-19 Pandemic and a National Lockdown on Hospitalizations for Venous Thromboembolism and Pulmonary Embolism in France
-
Abstract Number: PB1156
Impact of Thrombophilia Testing in Splanchnic Vein Thrombosis Management
-
Abstract Number: PB1302
Impact of Tissue Factor Pathway Inhibitor Gene Polymorphisms (33T/C and 264V/M) on Plasma TFPI Levels and their Influence on Risk of Recurrent Pregnancy Loss in India
-
Abstract Number: LPB0119
Impact of Vancomycin-induced Shift of the Gut Microbiome in Gram Negative Direction on Plasma Factor VIII:C Levels: Results from a Randomized, Controlled Trial
-
Abstract Number: OC 10.2
Impairment of Platelet Purinergic Signaling in Sickle Cell Disease
-
Abstract Number: PB1217
Implementation of a Multidisciplinary Surveillance Team to Improve Inferior Vena Cava Filter Retrieval and Outcomes
-
Abstract Number: PB0696
Implementation of a National Reference Service for Activity Testing, Typing, and Genotyping of Hereditary Factor XIII Deficiency (Project BR-13)
-
Abstract Number: OC 07.1
Implementation of Tele-guidance for Patient Self-imaging of Arthropathic Joints Using Mobile Ultrasound Devices –– Results from a Pilot Study
-
Abstract Number: PB1009
Importance of Consideration to Differetial Diagnosis of ITP
-
Abstract Number: PB0883
Importance of Platelet’s Sialic Acid Residues on Haemostasis and Immune System of Patients with Immune Thrombocytopenia
-
Abstract Number: PO133
IMPROVE Score and Coagulopathy Screening in Coronavirus Disease 2019 Patients
-
Abstract Number: OC 06.1
Improved Overall Survival with Warfarin Compared with Direct Oral Anticoagulants in Cancer-associated Venous Thromboembolism: A SEER-medicare Analysis
-
Abstract Number: LPB0041
Improved Patient-reported Treatment Satisfaction with Rivaroxaban as Compared to Low Molecular Weight Heparins for Cancer Patients with Acute Venous Thromboembolism – Results from the CONKO-011 Trial
-
Abstract Number: PO108
Improving of the of Biomechanical Parameters in an Experimental Animal Abdominal Aorta Model of Thick- cap Fibroatheromatic Plaque Using Ultrasound-guided High-dose Atorvastatin-loaded PESDA Microbubbles and Low Level Focused Shock Waves
-
Abstract Number: OC 65.3
Improving Outcomes with Integrated Care of Patients with Atrial Fibrillation and Multimorbidity Using Mobile Health Technology: A Report from the mAFA II Trial
-
Abstract Number: NUR 01.3
Improving Post-Thrombotic Syndrome (PTS) Care in Children: A Child’s Voice
-
Abstract Number: PB0793
In Children Receiving Long-term Anticoagulation Decreased Bone Mineral Density is Associated with Pubertal Development
-
Abstract Number: PB0566
In vitro Analysis of Coagulation Function in Emicizumab-treated Hemophilia A Patients with Inhibitors under Immune Tolerance Induction Treatment
-
Abstract Number: PB0362
In vitro Neutralization of Unfractionated Heparin for the Measurement of Thrombin Generation with the STG-drugScreen Reagent on ST Genesia
-
Abstract Number: PB1082
Inappropriate Direct Oral Anticoagulant Dosing in a Spanish Cohort with Atrial Fibrillation
-
Abstract Number: PB0763
Incidence and Correlation of Thrombocytopenia to Blood Stream Infections; Does this Correlation Really Matter?
-
Abstract Number: PB1100
Incidence and Impact of Venous Thromboembolism and Major Bleeding in Patients with Glioblastoma
-
Abstract Number: OC 64.4
Incidence and Predictors of Post-thrombotic Syndrome: Results from GARFIELD-VTE
-
Abstract Number: PB1207
Incidence and Treatment Pattern of Venous Thromboembolism from 2014 to 2018: The 3rd Korean Nationwide Study
-
Abstract Number: PB0438
Incidence Comparison and The Antiplatelet Effect on Bleeding Risk Between Chronic Kidney Disease Undergoing Haemodialysis and Peritoneal Dialysis: A Meta-analysis of Cohort Studies
-
Abstract Number: PB0267
Incidence of Disseminated Intravascular Coagulation (DIC) in Critical Patients with Covid-19
-
Abstract Number: PB0860
Incidence of Heparin Induced Thrombocytopenia 2009-2017: Analysis of the National Inpatient Sample Database
-
Abstract Number: PB0861
Incidence of Heparin-induced Thrombocytopenia in Patients Treated with Mechanical Circulatory Support: Results from a Prospective Study
-
Abstract Number: PB0302
Incidence of Spontaneous Iliopsoas Hematoma in COVID-19 Patients
-
Abstract Number: PB1231
Incidence of Thrombohaemorrhagic Complications in the Periprocedural of Oral Anticoagulant Treatment with Vitamin K Antagonists
-
Abstract Number: PB1166
Incidence of Thrombosis in Patients with MTHFR C677T Homozygosity and Hyperhomocysteinemia
-
Abstract Number: PB1206
Incidence of Venous Thromboembolic Disease during Primary Hyperparathyroidism: A 20-year Single Center Study
-
Abstract Number: PB0505
Incorporating Patient Reported Outcomes into Clinical Practice: A 360-degree Clinical Evaluation for Better Care and Treatment of People with Hemophilia through myWBDR and myPROBE
-
Abstract Number: PB0916
Increased Cleavage of VWF by ADAMTS13 Might Reduce High-molecular-weight VWF Multimers, Leading to Acquired von Willebrand Syndrome in Patients with Essential Thrombocythemia
-
Abstract Number: OC 17.2
Increased Levels of Coagulation Factor V in Atherosclerotic Plaques – An Immune Regulated Response?
-
Abstract Number: OC 33.3
Increased Plasma Concentration of Pentraxin 3 and Fibroblast Growth Factor 2 in Preeclampsia
-
Abstract Number: PB0496
Increased Prevalence of Age-related Comorbidities and Health Service Utilization among Adult Men with Hemophilia in Alberta, Canada
-
Abstract Number: PB0705
Increased Risk for Re-bleeding after Hemostatic Challenges in Patients with a Mild to Moderate Bleeding Tendency
-
Abstract Number: PB0146
Increased Thrombin Generation in COVID-19 is Mediated by Platelet-dependent and -Independent Mechanisms
-
Abstract Number: PB0198
Increased von Willebrand Factor (VWF) and Factor VIII (FVIII) Levels in Severe Acute Respiratory Syndrome Sars-Cov2-positive Pneumonia Compared with Severe Acute Respiratory Syndrome Sars-Cov2-negative: A Case-control Study
-
Abstract Number: PB0242
Indices of the Hemostasis System in Patients with COVID-19 Depending on the Outcome
-
Abstract Number: OC 57.2
Individual Benefits and Harms of Extended Anticoagulation in Patients with Venous Thromboembolism: The VTE-PREDICT Model
-
Abstract Number: PB0046
Induced Forms of α2-Macroglobulin Neutralize Heparin and Direct Oral AntiCoagulant Effects
-
Abstract Number: PB0648
Infectious Complications in Hemophilia Patients
-
Abstract Number: PB0460
Influence of Activated Factor XI on Simultaneous Thrombin Generation and Fibrin Clot Lysis in Factor Deficiencies
-
Abstract Number: PB0243
Influence of C-reactive Protein on Thrombin Generation Assay
-
Abstract Number: PB0061
Influence of Low-generation Polyamidoamine (PAMAM) Dendrimers on Structure and Function of Fibrinogen, Generation, Amidolytic and Coagulating Activity of Thrombin in vitro
-
Abstract Number: PB0069
Influence of Para-sulfonato-calixarenes on Components of Coagulation System
-
Abstract Number: PB0621
Influence of Pregnancy on the Pharmacokinetic Profile of a Severe Hemophilia A Female
-
Abstract Number: PB0062
Influence of Tissue-factor Pathway Inhibitor on Thrombin Generation Assay
-
Abstract Number: PB0802
Inherited Antithrombin Deficiency in Childhood: A Multicenter National Study
-
Abstract Number: PB0719
Inherited Factor XIII Deficiency: A Mild and a Severe Case Reports
-
Abstract Number: OC 43.3
Inhibition of ADAMTS13 Rescues Acquired von Willebrand Syndrome in a Preclinical Left Ventricular Assist Device Animal Model
-
Abstract Number: PB0995
Inhibition of ADP and Thromboxane A2 Production Results in Decreased Global Platelet Contraction, but Thromboxane A2 Inhibition Plays a Greater Role in Limiting Local Platelet Contraction
-
Abstract Number: OC 28.1
Inhibition of Neutrophil Extracellular Traps Reveals their Differential Role in the Pathogenesis of Abdominal Aortic Aneurysms in Distinct Mouse Models
-
Abstract Number: LPB0131
Inhibition of Surface-induced Platelet Activation on Hydrogel Films
-
Abstract Number: OC 73.1
Inhibition of Thrombin Activatable Fibrinolysis Inhibitor (TAFI) to Accelerate Clot Lysis in Patients with Acute Pulmonary Embolism: A Phase 2 Randomized Study
-
Abstract Number: PB0500
Inhibitor Development upon Switch from Plasma-derived to Recombinant FVIII in PUPs with Severe Haemophilia A: Preliminary Analysis from the PUP-SWITCH Study
-
Abstract Number: PB0647
Inhibitors in Non Severe Haemophilia A (NS-HA): A Case Report
-
Abstract Number: OC 28.2
Innocuous Levels of Pulmonary Thrombosis Protect against Inflammatory Lung Injury via Endothelial Alox15 and HIF1α
-
Abstract Number: PB1170
Inpatient Thrombophilia Testing – Adding Unnecessary Cost to the Clot?
-
Abstract Number: PB1024
Integrin αIIbβ3 Regulates Platelet Procoagulant Activity in the Lung
-
Abstract Number: OC 19.4
Interaction between the Von Willebrand Factor and ADAMTS13 on VTE Risk in Women. Results from the Retrove Project
-
Abstract Number: PB1006
Interaction of Blood Platelets with Engineered Fibrinogen Scaffolds of Different Topographies
-
Abstract Number: PB0122
Interaction of Phenyramidol HCl and Warfarin: A Case Series Report
-
Abstract Number: PB0103
Interaction of the Factor IXa with the Subpopulations of Activated Platelets
-
Abstract Number: PB1297
Interactions of Anemia with Race and Peripartum Transfusion in Three Large US Registries
-
Abstract Number: PB0506
Interim Analysis of the PREVENT Study: Real World Prospective Data from Children and Adolescents with Haemophilia A or B Treated with Recombinant Factor VIII Fc (rFVIIIFc) or Recombinant Factor IX Fc (rFIXFc)
-
Abstract Number: OC 28.3
Interleukin-4 Signaling Enhances Survival of Circulating Monocytes in vivo
-
Abstract Number: PO111
Intermediate Stage Atherosclerosis Regression Using Lipid-based Encapsulated Methotrexate Nanoparticles-mediated B-mode Ultrasound-guided Pulsed Low Level Focused Ultrasound Sonoporation Therapy
-
Abstract Number: PB0948
Intermittent Prophylaxis for Heavy Menstrual Bleeding in Von Willebrand Disease
-
Abstract Number: PB1267
International Multicentric Study: Laboratory in Patients Treated with Apixaban or Rivaroxaban in Latin America (Larila): Final Results
-
Abstract Number: PB1229
International Survey of Secondary Thromboprophylaxis Practice Patterns in Pediatrics
-
Abstract Number: PB0581
Intracranial Haemorrhage (ICH) in Egyptian Children with Haemophilia A and B: A 15 Year Retrospective Single Center Study
-
Abstract Number: PB0610
Intracranial Hemorrhage in Hemophiliac Patients at Chiang Mai University Hospital: A 10-year Retrospective Study
-
Abstract Number: LPB0078
Intracranial Involvement and Neurologic Manifestations in Lemierre Syndrome: Analysis of 712 Patients
-
Abstract Number: LPB0030
Investigating Impact of von Willebrand Factor Deficiencies on the Biogenesis of Weibel-Palade Bodies and Endothelial Cells Signaling Pathways
-
Abstract Number: PB0920
Investigating Pathomolecular Mechanisms von Willebrand Disease Variants Located in a Domains of the von Willebrand Factor
-
Abstract Number: OC 66.1
Investigating the Resistance of ADAMTS13 towards Protease Inhibitors
-
Abstract Number: PB1034
Investigation of Core and Shell Platelet Mechanics through P2Y12 Antagonism
-
Abstract Number: OC 75.2
Investigation of Early Outcomes Following Adeno-associated Viral Gene Therapy in a Canine Hemophilia Model
-
Abstract Number: PO169
Investigation of Hereditary Thrombophilia in Women with Recurrent Fetal Loss in LUMHS Hyderabad
-
Abstract Number: OC 20.2
Investigation of Preterm Intraventricular Hemorrhage Induced Inflammatory Response and microRNA Levels by Heme and Hypoxia in Human Choroid Plexus Epithelial Cells
-
Abstract Number: PB0010
Investigation of Red Blood Cells Influence on Atherosclerotic Plaque by Scanning Flow Cytometry
-
Abstract Number: PB0899
Investigation of the Epidemiology of Inherited Platelet Disorders in Patients Attending the Royal Hospital, Muscat, Oman
-
Abstract Number: PB0867
Investigations of the Impact of Sialidase-mediated Changes on Bleeding Using a Humanized in vivo Mouse Model
-
Abstract Number: PB0991
Iron Repletion Decreases Platelet Count in Iron Deficient Premenopausal Women
-
Abstract Number: PB1139
Is Hematopoietic Clonality of Indetermined Potential a Risk Factor for Pulmonary Embolism?
-
Abstract Number: PB0015
Is Microvessel Perfusion Associated with Platelets in Acute Cerebrovascular Disorders?
-
Abstract Number: PB0273
Is Procalcitonin Involved on the Severity of COVID-19?
-
Abstract Number: LPB0143
Is standard dose thromboprophylaxis (TP) as recommended by the Royal College of Obstetricians and Gynaecologists (RCOG) adequate in pregnancy for women with prior venous thrombo-embolism (VTE)?
-
Abstract Number: PB0474
Is Standardisation the Key? FVIII Inhibitor Results: A UK National External Quality Assessment Scheme for Blood Coagulation (UK NEQAS BC) Exercise
-
Abstract Number: PO113
Is There an Association of Diffuse Large B-cell Lymphoma with Coronary Artery Disease?
-
Abstract Number: PB0161
Is Viscoelastometric Testing a Good Tool to Assess Hemostasis of COVID-19 Patients?
-
Abstract Number: PB0484
Is Zero Bleeds a Realistic Goal for Hemophilia Patients in the Real World Setting?
-
Abstract Number: PB0539
Is Zero Bleeds in PWH an Achievable Goal? 3 Years of Emicizumab in Persons with Hemophilia A and Inhibitors in a Portuguese Hemophilia Treatment Centers
-
Abstract Number: PB1176
ISTH Definition of Pulmonary Embolism-related Death and Classification of the Cause of Death in Venous Thromboembolism Studies: An Autopsy Study
-
Abstract Number: PB1209
ISTH Membership and Research Output: A Comparative Study of Sub-Saharan Africa and Europe
-
Abstract Number: OC 33.1
ISTH Registry on Pregnancy and COVID-19 Associated Coagulopathy (COV-PREG-COAG) – First Report
-
Abstract Number: PB0169
ITP Secondary to COVID-19: A Comprehensive Review of Reported Cases
ISTH 2021 Congress
July 17-21, 2021. Philadelphia, PA.